Recombinant proteins for gene delivery and insertion
OwnerYaron BEN SHUSHAN-GOLECZKI, Noga KOWALSMAN +1inventors
InventorsYaron BEN SHUSHAN-GOLECZKI, Noga KOWALSMAN, Devin TRUDEAU
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions and methods for delivering a gene of interest to a subject. Aspects of the application relate to nucleic acids encoding modified retroelement-derived polypeptides and gene delivery constructs that can direct integration of a nucleic acid sequence into a target nucleic acid (e.g., a genome of a subject).
Claims35
A nucleic acid encoding an engineered protein comprising a retroelement-derived polypeptide and at least one heterologous polypeptide-;
- wherein the retroelement-derived polypeptide is derived from a non-long terminal repeat (non-LTR) retrotransposon, wherein the non-LTR retrotransposon is an apurinic/apyrimidinic endonucleases (APE)-type retrotransposon selected from a ZFL2-2 retrotransposon, a Vingi-1_Acar retrotransposon, a Vingi-2_Acar retrotransposon, a L2-18_Acar retrotransposon, or a CR1-1_Acar retrotransposon;
- wherein the at least one heterologous polypeptide comprises an RNA/DNA processing polypeptide or domain thereof, an RNA/DNA repair polypeptide or domain thereof, a nucleic acid binding polypeptide or domain thereof, or a nucleosome binding polypeptide or domain thereof, and
- wherein the engineered protein exhibits at least one improved integration characteristic, as compared to a retroelement-derived polypeptide not fused to the at least one heterologous polypeptide.
-3. (canceled)
(canceled)
(canceled)
(canceled)
-21. (canceled)
-26. (canceled)
-30. (canceled)
-35. (canceled)
-54. (canceled)
-126. (canceled)
-130. (canceled)
-160. (canceled)
(canceled)
-166. (canceled)
Dependencies are inferred from the claim text.